Based on these findings, Sarris et al. conducted in vivo investigations using chemically induced tumors in Smyd3-deficient, Smyd3-wild type, and Smyd3-overexpressed mice (these results are described in paragraph one of the colorectal cancer section) [36]. The gene discussed is SMYD3; the disease is colorectal cancer.